Ticker League

Total Debt for Bristol-Myers Squibb (BMY)

As of · Reported

Metric

Latest period

$44.46B

YoY change

-7.9%

5Y CAGR

-1.8%

Peak year (2020)

$51.67B

Total Debt history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: $47.14B

Total Debt growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: -7.9%

Total Debt history table for Bristol-Myers Squibb (BMY) from 1987 to 2025

  • 2025$47.14B-7.9%
  • 2024$51.20B+23.5%
  • 2023$41.46B+1.8%
  • 2022$40.72B-10.7%
  • 2021$45.60B-11.8%
  • 2020$51.67B+8.7%
  • 2019$47.54B+546.9%
  • 2018$7.35B-7.7%
  • 2017$7.96B+18.7%
  • 2016$6.71B+0.3%
  • 2015$6.69B-14.6%
  • 2014$7.83B-6.1%
  • 2013$8.34B+12.8%
  • 2012$7.39B+34.7%
  • 2011$5.49B+0.8%
  • 2010$5.45B-14.4%
  • 2009$6.36B-5.6%
  • 2008$6.74B+7.4%
  • 2007$6.27B-15.6%
  • 2006$7.43B-13.5%
  • 2005$8.60B-16.9%
  • 2004$10.35B+18.2%
  • 2003$8.75B+14.6%
  • 2002$7.64B+19.2%
  • 2001$6.41B+328.0%
  • 2000$1.50B-15.6%
  • 1999$1.77B-3.9%
  • 1998$1.85B+1.3%
  • 1997$1.82B+23.2%
  • 1996$1.48B+22.2%
  • 1995$1.21B-11.6%
  • 1994$1.37B+79.0%
  • 1993$765.00M+38.8%
  • 1992$551.00M-19.9%
  • 1991$688.00M+9.6%
  • 1990$628.00M+21.2%
  • 1989$518.00M-46.2%
  • 1988$963.00M+38.8%
  • 1987$694.00M—

Total Debt values are taken from Bristol-Myers Squibb's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Total Debt at Bristol-Myers Squibb (BMY)

According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total debt is $44.46B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Bristol-Myers Squibb (BMY) total debt is $47.14B – declined 7.9% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Bristol-Myers Squibb total debt compounded at -1.8% per year, with a net decline across the window.

The record annual total debt stands at $51.67B, reached in 2020; the historical low of $518.00M was recorded in 1989.

Bristol-Myers Squibb Total Debt by Year

Bristol-Myers Squibb Total Debt 2025: $47.14B

2025's total debt for Bristol-Myers Squibb came in at $47.14B, declined 7.9% below 2024.

Bristol-Myers Squibb Total Debt 2024: $51.20B

Bristol-Myers Squibb posted total debt of $51.20B in 2024, grew 23.5% from 2023.

Bristol-Myers Squibb Total Debt 2023: $41.46B

In 2023, Bristol-Myers Squibb reported total debt of $41.46B, edged up 1.8% from 2022.

Bristol-Myers Squibb Total Debt 2022: $40.72B

Bristol-Myers Squibb total debt in 2022 was $40.72B, declined 10.7% below 2021.

Bristol-Myers Squibb Total Debt 2021: $45.60B

Bristol-Myers Squibb total debt in 2021 was $45.60B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Total Debt

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest total debt

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview